Related Articles
Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease
Adipose tissue-derived stem cells promote the reversion of non-alcoholic fatty liver disease: An in vivo study
Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
Berberine attenuates hepatic oxidative stress in rats with non‑alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation